SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-20-014575
Filing Date
2020-03-31
Accepted
2020-03-31 17:06:36
Documents
9
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 6-K lmnl-6k_20200331.htm 6-K 22518
2 EX-99.1 lmnl-ex991_16.htm EX-99.1 8373817
3 GRAPHIC g4wcxuzbxmqt000011.jpg GRAPHIC 7615
4 GRAPHIC g4wcxuzbxmqt000012.jpg GRAPHIC 5273
5 GRAPHIC g4wcxuzbxmqt000003.jpg GRAPHIC 851
6 GRAPHIC g4wcxuzbxmqt000001.jpg GRAPHIC 28127
7 GRAPHIC g4wcxuzbxmqt000002.jpg GRAPHIC 4060
8 GRAPHIC g4wcxuzbxmqt000013.jpg GRAPHIC 7615
9 GRAPHIC g4wcxuzbxmqt000004.jpg GRAPHIC 38195
  Complete submission text file 0001564590-20-014575.txt   8524867
Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4
Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 514-341-2115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39131 | Film No.: 20762664
SIC: 2834 Pharmaceutical Preparations